National studies

Blood Borne Pathogens Surveillance Program (BBPSP)
Investigation of Clotting Factor Activity Heterogeneity in Severe Hemophilia A
Health-related Quality of Life in von Willebrand's Disease

Canadian pediatric prophylaxis study - contact Dr. Victor Blanchette
Canadian inhibitor surveillance study - contact Dr. Manuel Carcao
        Queen's University
          Department of Pathology and Molecular Medicine           
          Richardson Laboratory, Room 201
          88 Stuart Street
          Kingston, ON K7L 3N6
          Attn: Angie Tuttle
          Ph: 613 533-2822
          Fax: 613 533-2907
          E-Mail: tuttlea@queensu.ca

National genotyping Study - contact Dr. David Lillicrap
National Program for Hemophilia Mutation Testing Department of Pathology
         Richardson Laboratory, Room 201 Queen's University Stuart Street
         Kingston, ON K7L 3N6
         attn: Jayne Leggo
         Jayne Leggo <nphmt@clinlabs.path.queensu.ca>
         ph: 613 533-3187
         fax: 613 533-2907

Pediatric Disease Specific Quality of Life study
- contact Dr. Patricia McCusker

International studies:

International Immune Tolerance Inhibition study
International sib pair study of inhibitor formation - funded by Baxter
Adult Quality of Life study - funded by Bayer
Hemophilia Inhibitor Genetics Study (HIGS)

OPEN STUDIES

Seven Treatment Evaluation Registry